Amneal Pharmaceuticals (AMRX) News Today $8.47 -0.53 (-5.89%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Down 16.3% in OctoberAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 3,500,000 shares, a decrease of 16.3% from the October 15th total of 4,180,000 shares. Approximately 2.9% of the company's stock are short sold. Based on an average trading volume of 1,190,000 shares, the days-to-cover ratio is presently 2.9 days.November 15 at 1:36 PM | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Raised to "Strong-Buy" at StockNews.comNovember 14 at 1:31 AM | americanbankingnews.comPiper Sandler Forecasts Strong Price Appreciation for Amneal Pharmaceuticals (NASDAQ:AMRX) StockNovember 13, 2024 | americanbankingnews.comAmneal Pharmaceuticals (NASDAQ:AMRX) Sets New 12-Month High on Analyst UpgradeNovember 13, 2024 | americanbankingnews.comAmneal Pharmaceuticals price target raised to $11 from $9 at Piper SandlerNovember 11, 2024 | markets.businessinsider.comAmneal Pharmaceuticals (NASDAQ:AMRX) Hits New 12-Month High Following Analyst UpgradeAmneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 1-Year High on Analyst UpgradeNovember 11, 2024 | marketbeat.comPiper Sandler Issues Positive Forecast for Amneal Pharmaceuticals (NASDAQ:AMRX) Stock PricePiper Sandler lifted their price target on shares of Amneal Pharmaceuticals from $9.00 to $11.00 and gave the stock an "overweight" rating in a research note on Monday.November 11, 2024 | marketbeat.comAmneal Pharmaceuticals Reports Strong Third Quarter 2024 Financial ResultsNovember 11, 2024 | americanbankingnews.comAmneal Pharmaceuticals, Inc. (NYSE:AMRX) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | msn.comAmneal Pharmaceuticals Reports Q3 2024 Financial ResultsNovember 9, 2024 | markets.businessinsider.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Sold by Nisa Investment Advisors LLCNisa Investment Advisors LLC lowered its position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 96.9% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 7,069 shares of the company's stock after selling 221,848 shares durNovember 9, 2024 | marketbeat.comAmneal Pharmaceuticals, Inc. (AMRX) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | seekingalpha.comAmneal Pharmaceuticals backs FY24 adjusted EPS view 57c-63c, consensus 60cNovember 8, 2024 | markets.businessinsider.comGeneric Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual ForecastsNovember 8, 2024 | finance.yahoo.comAmneal Pharmaceuticals Swings to 3Q Loss While Sales ClimbNovember 8, 2024 | marketwatch.comAmneal Pharmaceuticals Profit Slips, Yet Beats Estimates; Backs Annual Outlook In Line With ViewNovember 8, 2024 | markets.businessinsider.comAmneal Pharmaceuticals (NASDAQ:AMRX) Releases FY 2024 Earnings GuidanceAmneal Pharmaceuticals (NASDAQ:AMRX) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.570-0.630 for the period, compared to the consensus estimate of 0.600. The company also issued revenue guidance of $2.7 billionillion-$2.8 billionillion, compared to the consensus estimate of $2.8 billionillion.November 8, 2024 | marketbeat.comAmneal Reports Third Quarter 2024 Financial ResultsNovember 8, 2024 | businesswire.comAmneal Pharmaceuticals (AMRX) Receives a Buy from BarclaysNovember 8, 2024 | markets.businessinsider.comEarnings Outlook For Amneal PharmaceuticalsNovember 7, 2024 | benzinga.comAmneal Pharmaceuticals Q3 2024 Earnings PreviewNovember 7, 2024 | msn.comWhat's Next: Amneal Pharmaceuticals's Earnings PreviewNovember 7, 2024 | benzinga.comEarnings To Watch: Amneal Pharmaceuticals Inc (AMRX) Reports Q3 2024 ResultNovember 7, 2024 | finance.yahoo.comZacks.com featured highlights include Amneal Pharmaceuticals, Cronos Group, Carriage Services, Business First Bancshares and AmphenolNovember 6, 2024 | au.finance.yahoo.comAmneal Pharmaceuticals (AMRX) Scheduled to Post Quarterly Earnings on FridayAmneal Pharmaceuticals (NASDAQ:AMRX) will be releasing earnings before the market opens on Friday, November 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=633918)November 1, 2024 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) grows 3.0% this week, taking five-year gains to 211%October 31, 2024 | finance.yahoo.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Sees Significant Decline in Short InterestAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 4,180,000 shares, a decrease of 7.7% from the September 30th total of 4,530,000 shares. Based on an average daily volume of 1,230,000 shares, the short-interest ratio is presently 3.4 days. Approximately 3.5% of the company's shares are short sold.October 30, 2024 | marketbeat.comAssenagon Asset Management S.A. Raises Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Assenagon Asset Management S.A. grew its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 114.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,204,994 shares of the company's stock afOctober 28, 2024 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the five research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation anOctober 26, 2024 | marketbeat.comAmneal Pharmaceuticals receives FDA approval of Pyridostigmine Bromide NDAOctober 22, 2024 | markets.businessinsider.comAmneal Pharmaceuticals Gets FDA Approval for Pyridostigmine BromideOctober 21, 2024 | marketwatch.comAmneal Pharma: FDA Approves NDA For Pyridostigmine Bromide Extended-Release TabletsOctober 21, 2024 | markets.businessinsider.comAmneal Pharmaceuticals (NASDAQ:AMRX) Sets New 12-Month High - What's Next?Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 12-Month High - Here's WhyOctober 16, 2024 | marketbeat.comSG Americas Securities LLC Buys Shares of 63,844 Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)SG Americas Securities LLC purchased a new position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 63,844 shares of the company's stock, valued at approximatelyOctober 16, 2024 | marketbeat.comCoya Therapeutics Has Several Near-Term Share Price Appreciation CatalystsOctober 13, 2024 | seekingalpha.comAmneal Pharmaceuticals Inc (AMRX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...October 9, 2024 | finance.yahoo.comSei Investments Co. Raises Stock Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Sei Investments Co. raised its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 257.9% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 127,100 shares of the company's stock after acquiring an additional 91,584 shares during theOctober 9, 2024 | marketbeat.comUS-headquartered Amneal Pharmaceuticals to invest up to USD 200 mn in India to set up 2 plantsOctober 8, 2024 | msn.comAQR Capital Management LLC Has $2.76 Million Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)AQR Capital Management LLC lessened its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 42.5% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 435,082 shares of the company's stock afOctober 8, 2024 | marketbeat.comAmerican Century Companies Inc. Lowers Stock Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)American Century Companies Inc. trimmed its position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 85.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 33,314 shares of the company's stock afterOctober 5, 2024 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Sold by Hsbc Holdings PLCHsbc Holdings PLC lessened its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 85.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 43,841 shares of the company's stock after sellingOctober 4, 2024 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Acquired by Dimensional Fund Advisors LPDimensional Fund Advisors LP lifted its position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 17.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 4,283,928 shares of the company's stock after buying an additional 641,405 shaOctober 3, 2024 | marketbeat.comAmneal Pharmaceuticals (AMRX) Gets a Buy from Truist FinancialOctober 2, 2024 | markets.businessinsider.comAmneal Pharmaceuticals (NASDAQ:AMRX) Price Target Raised to $12.00Truist Financial boosted their price objective on shares of Amneal Pharmaceuticals from $10.00 to $12.00 and gave the stock a "buy" rating in a research report on Wednesday.October 2, 2024 | marketbeat.comAmneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic DiseasesOctober 1, 2024 | finance.yahoo.comAmneal To Become Metsera's Preferred Supply Partner For Developed Markets - Quick FactsOctober 1, 2024 | markets.businessinsider.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Recommendation of "Moderate Buy" by BrokeragesAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the five research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have givOctober 1, 2024 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest UpdateAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) was the target of a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 4,640,000 shares, an increase of 8.7% from the August 31st total of 4,270,000 shares. Based on an average daily trading volume, of 1,440,000 shares, the days-to-cover ratio is currently 3.2 days. Approximately 3.9% of the company's shares are sold short.September 29, 2024 | marketbeat.comRenaissance Technologies LLC Increases Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Renaissance Technologies LLC grew its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 28.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 682,700 shares of the company's stock after buyiSeptember 29, 2024 | marketbeat.comPharmaceutical company sues Colorado over epinephrine price-cap lawSeptember 28, 2024 | msn.com Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address How one pattern has averaged an 85% return per year since the pandemic. (Ad)Over the last 5 years Roger Scott has done some pretty incredible things… He’s found hundreds of winning opportunities… He’s created some incredible strategies… And he’s even designed some amazing tools… But there is one thing he’s always kept close to the chest… And in this case, it’s been a very particular stock market pattern…. A pattern he calls the World's Most Predictable Pattern… Follow this link here and enter your email address to sign up… AMRX Media Mentions By Week AMRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMRX News Sentiment▼0.840.56▲Average Medical News Sentiment AMRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMRX Articles This Week▼114▲AMRX Articles Average Week Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMPH News Today PRGO News Today COLL News Today FHTX News Today EGRX News Today SRPT News Today CTLT News Today RVMD News Today QGEN News Today ITCI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMRX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amneal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMRX Stock Alerts